Knight Therapeutics (FRA:04K) Accounts Payable & Accrued Expense : €63.0 Mil (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Knight Therapeutics Accounts Payable & Accrued Expense?

Knight Therapeutics's quarterly accounts payable & accrued expense increased from Sep. 2023 (€59.6 Mil) to Dec. 2023 (€63.8 Mil) but then declined from Dec. 2023 (€63.8 Mil) to Mar. 2024 (€63.0 Mil).

Knight Therapeutics's annual accounts payable & accrued expense increased from Dec. 2021 (€51.9 Mil) to Dec. 2022 (€80.1 Mil) but then declined from Dec. 2022 (€80.1 Mil) to Dec. 2023 (€63.8 Mil).

Knight Therapeutics Accounts Payable & Accrued Expense Historical Data

The historical data trend for Knight Therapeutics's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Knight Therapeutics Accounts Payable & Accrued Expense Chart

Knight Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

77.01

37.94

51.88

80.10

63.84

Knight Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															76.00	67.67	59.58	63.84	63.03

Knight Therapeutics Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Knight Therapeutics (FRA:04K) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Knight Therapeutics Inc (FRA:04K) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

KHTRF:USA GUD:Canada

Address

3400 De Maisonneuve West, Suite 1055, Montreal, QC, CAN, H3Z 3B8

Website

https://www.gud-knight.com

Knight Therapeutics Inc is a specialty and generic drug manufacturing company. The company's principal business activity is focused on developing, acquiring, in-licensing, out-licensing, marketing, and distributing pharmaceutical products, consumer health products, and medical devices in Canada, Ltin America and select international markets. Knight finances other life sciences companies across the globe in order to generate interest income, strengthen relationships in the life sciences industry, and to secure product distribution rights.

Knight Therapeutics (FRA:04K) Headlines

No Headlines